Prospective randomized pilot study of Y90 +/− sorafenib as bridge to transplantation in hepatocellular carcinomaLaura Kulik, Riad Salem, Jonathan Cotliar et al.|Journal of Hepatology|2014Cited by 92
The Economic Impact of MELD on Liver Transplant CentersDavid A. Axelrod, Michaël Abécassis, Alan J. Koffron et al.|American Journal of Transplantation|2005Cited by 87
Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipientsJosh Levitsky, Joshua Miller, James M. Mathew et al.|Hepatology|2012Cited by 61
Plasma protein biomarkers enhance the clinical prediction of kidney injury recovery in patients undergoing liver transplantationJosh Levitsky, Michaël Abécassis, Talia Baker et al.|Hepatology|2014Cited by 55
Living Donor Liver Transplant for MalignancyDavid A. Axelrod, Michaël Abécassis, Laura Kulik et al.|Transplantation|2005Cited by 32